Problems in tetanus prophylaxis: the immune patient.
D000917:Antibody Formation; D004342:Drug Hypersensitivity; D006801:Humans; D013742:Tetanus / Q000276:immunology* / Q000517:prevention & control; D013743:Tetanus Antitoxin / Q000627:therapeutic use*; D013745:Tetanus Toxoid / Q000627:therapeutic use*
D013743:Tetanus Antitoxin; D013745:Tetanus Toxoid